Margaret O'Toole

Vice-President, Operations, LabCentral, Inc.

Maggie O’Toole is the vice president of operations at LabCentral. She provides overall direction and guidance to the operational activities of the company and oversees expansion projects including the Harvard Life Lab, a branch of the Harvard Innovation Labs operated by LabCentral as well as MIT's The Engine. Maggie has more than 20 years of experience in business start-ups working with the founders to establish a company’s infrastructure and ultimately is responsible for business management and daily operations. Prior to LabCentral, she served as director of operations for Pervasis Therapeutics, an early-stage biotech acquired by Shire. Previously, she has held management positions with Reputation Technologies; acquired by Security Source, Inc., Synetics, Inc.; acquired by ACS, and Elephant Engineering; acquired by Syntronics, LLC. Maggie earned her bachelor’s degree from Carnegie Mellon University.